CSG N.V.: Strong Growth, Record Backlog, Shares Slip — The Selloff Is Mispriced

CSG N.V. delivered a solid first half of 2026 and its shares slipped anyway. Revenue grew 17.2% to €3.25 billion. Operating EBIT rose 12.7% to €784 million, holding the margin at 24.1%. The company reaffirmed full-year guidance of €7.4 to €7.6 billion in revenue with a 24–25% operating EBIT margin. The total backlog and pipeline reached €46 billion — a record.

None of that stopped the stock from selling off on the news. The market reaction tells me the sell-side is fixated on what it sees as diversification risk away from Ukraine rather than recognizing the company's business has already broadened into something more durable. At a forward P/E of 15.6 times with a PEG ratio of 0.59, CSG is now priced like a slow-growth industrial, not a defense name compounding revenue at 17% and margins above 24%. That disconnect is what I'm focusing on.

The Ukraine Hedge Already Worked

The most visible concern investors are pricing in is CSG's exposure to Ukraine. Through the first half, Ukraine's share of revenue fell from 27% at year-end 2025 to 17%. That's a sharp drop, and on its own it would signal customer concentration risk. But the story the market is reading from that number misses the flip side: Europe, excluding Ukraine, now accounts for more than half of CSG's business.

This is not a company losing its biggest customer. It's a company whose biggest geographic market shifted from a single conflict-driven buyer to a diversified set of European NATO governments. That shift matters because European defense orders come with multi-year contracts, sovereign balance sheets, and the kind of political momentum behind rearmament that doesn't evaporate between elections.

The Land Systems division reinforces this point. Revenue in the segment doubled year-over-year in the first half, and it now represents 46% of the total order backlog. CEO Michal Strnad described the scaling as proceeding "exactly as planned." Whether you find that kind of phrasing reassuring or boilerplate, the metric behind it is unambiguous: a new growth engine inside CSG has moved from pipeline to production faster than the market has credited.

Margins Held Through the Shift

The operating EBIT margin stayed flat at 24.1% in both Q1 and H1. That's notable because you'd expect a company rapidly scaling new products and geographic channels to take some margin drag from ramp costs. CSG didn't. The company earned €372 million of EBIT in Q1 on €1.54 billion of revenue and pushed that to €784 million in H1 — meaning Q2 alone delivered €412 million of operating earnings.

For context, CSG reported €1.6 billion in adjusted operating EBIT on €6.7 billion of revenue for all of FY 2025, also at a 24.1% margin. The first half of 2026 generated nearly half of last year's full-year operating profit on roughly half of last year's revenue. Growth and profitability are moving in the same direction, which is the configuration where a multiple compression becomes a buying signal rather than a trap.

The Valuation Reset

This is where the stock becomes actionable. CSG trades at approximately €19.3 billion in market cap, with enterprise value at €21.5 billion. The trailing P/E sits at 23.1 times, but the forward P/E is 15.6 times — implying the market expects earnings to grow roughly 48% next year on the back of that €7.4–7.6 billion revenue range and sustained 24%+ margins.

A forward P/E of 15.6 on a company growing revenue at 17% and expanding earnings toward that 48% level is not rich. The PEG ratio — forward P/E divided by the expected earnings growth rate — comes in at 0.59. A PEG below 1.0 means the market is paying less than one euro of price for every euro of expected earnings growth. That's the kind of number you see when a fundamentally sound company gets sold into because a narrative risk feels uncomfortable, not because the math has broken.

On an EV/EBITDA basis, CSG trades at 11.9 times. The EV/EBIT multiple is 13.2. Either way, the enterprise is valued at roughly 12–13 times operating earnings while growing revenue at 17% and maintaining margins above 24%. That multiple would be generous for a mature prime defense contractor with single-digit growth. For a company adding €46 billion in backlog and pipeline and doubling its fastest-growing segment, it's compressed.

The Free Cash Flow Caveat

One area where the valuation tells a different story is free cash flow. CSG trades at 80.5 times free cash flow, with a FCF yield of just 1.24%. That looks expensive by comparison, and it's worth understanding why. Defense manufacturers operating in a capacity-constrained, high-demand environment typically reinvest aggressively — expanding production lines, acquiring suppliers, and building out Land Systems. That capital intensity depresses near-term free cash flow even as operating earnings compound.

The question for investors is whether that reinvestment pays off. The €46 billion backlog provides multi-year revenue visibility. Vertical integration — CSG owns the production chain from raw materials to finished ammunition and systems — means the capex goes into proprietary capacity rather than contractual outsourcing. If execution holds, the free cash flow multiple should compress as revenue scales through that existing capacity. If the ramp slows or margins erode, the FCF multiple stays stretched and becomes a real concern.

The Catalyst Clock

The next public data point is the Q3 2026 trading update on November 11. That's the closest thing to an earnings read for the back half of the year. Between now and then, the stock's trajectory depends on whether the market continues to punish geographic diversification or starts to reward the scale CSG is building in Land Systems and European contracts.

The US expansion is also a forward catalyst, though management only described it as a "growing component" without giving specific revenue or order figures. The company also made a minority investment in North Vector Dynamics, a move that signals its push into advanced defense technologies beyond ammunition. Neither detail is priced in yet, and both would benefit from more specificity in the November update.

Risks

Three risks keep this from being a conviction buy at full position size:

• Ukraine tail risk: The reduction from 27% to 17% doesn't eliminate exposure. A further drop in Ukrainian demand — whether from conflict dynamics, funding constraints, or supply chain shifts — would pressure top-line growth if European orders don't fully offset it.
• Capacity execution: Land Systems doubling year-over-year sounds strong until you remember that ramping physical production involves factory builds, labor hiring, quality control, and delivery timelines. Execution risk in a newly scaled division is real.
• FCF intensity: That 1.24% free cash flow yield means the stock is not a yield play or a cash-return story right now. Investors need to be comfortable holding for earnings growth rather than cash distribution.

Verdict

CSG N.V. is a defense company growing revenue at 17%, maintaining a 24.1% operating margin, and sitting on a €46 billion backlog — all of which should command a multiple above what the market is offering. The share price decline into the H1 results points to sellers running from a geographic diversification narrative rather than from deteriorating fundamentals. The business hasn't deteriorated. The multiple has.

At a forward P/E of 15.6 and a PEG of 0.59, the valuation has reset faster than the operating profile warrants. I'm buying into the selloff. TheNovember trading update is the next proof point, and I'd want to see Land Systems continue its growth trajectory and European contracts hold their pace. If those hold, this stock earns its multiple back — and likely more.

Rating: Buy.